Moreover, ZZW-115, a NUPR1 inhibitor, induces apoptosis and necroptosis in HCC cells, resulting in pronounced mitochondrial dysfunction and a marked reduction in ATP levels, making it a viable pharmacological candidate for patients with HCC [33]. This evidence concerns the gene NUPR1 and hepatocellular carcinoma.